home / stock / brkr / brkr quote
Last: | $78.68 |
---|---|
Change Percent: | 0.15% |
Open: | $79.1 |
Close: | $78.56 |
High: | $79.45 |
Low: | $78.26 |
Volume: | 286,020 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$78.68 | $79.1 | $78.56 | $79.45 | $78.26 | 286,020 | 04-19-2024 |
$78.56 | $79.442 | $78.56 | $80.9 | $77.12 | 2,217,725 | 04-18-2024 |
$82.94 | $84.9 | $82.94 | $84.9 | $82.67 | 695,720 | 04-17-2024 |
$83.89 | $85.82 | $83.89 | $85.82 | $83.761 | 819,517 | 04-16-2024 |
$85.75 | $88.26 | $85.75 | $88.51 | $85.1 | 572,961 | 04-15-2024 |
$87.58 | $89.47 | $87.58 | $90.03 | $87.21 | 545,504 | 04-12-2024 |
$90.28 | $89.53 | $90.28 | $90.56 | $88.88 | 473,261 | 04-11-2024 |
$88.53 | $88.21 | $88.53 | $89.41 | $87.7937 | 469,728 | 04-10-2024 |
$90.02 | $90.5 | $90.02 | $90.715 | $89.28 | 510,948 | 04-09-2024 |
$90.23 | $90.54 | $90.23 | $91.34 | $89.57 | 666,965 | 04-08-2024 |
$90.42 | $89.77 | $90.42 | $91.465 | $89.34 | 533,746 | 04-05-2024 |
$89.77 | $91.59 | $89.77 | $91.8611 | $89.68 | 343,690 | 04-04-2024 |
$91 | $90.5 | $91 | $91.48 | $90.5 | 534,987 | 04-03-2024 |
$90.91 | $92.93 | $90.91 | $92.93 | $90.41 | 480,553 | 04-02-2024 |
$92.93 | $93.99 | $92.93 | $94.35 | $92.575 | 399,738 | 04-01-2024 |
$93.94 | $94.04 | $93.94 | $94.52 | $93.15 | 438,700 | 03-29-2024 |
$93.94 | $94.04 | $93.94 | $94.52 | $93.15 | 438,700 | 03-28-2024 |
$93.86 | $93.43 | $93.86 | $93.86 | $92.56 | 327,350 | 03-27-2024 |
$92.4 | $92.99 | $92.4 | $93.45 | $92.15 | 442,881 | 03-26-2024 |
$93.07 | $94.15 | $93.07 | $94.64 | $92.66 | 586,134 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membran...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and...
Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics Complementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing immunoassay platfo...